Acute respiratory distress syndrome (ARDS) is a complex syndrome of acute lung injury
leading to noncardiogenic pulmonary edema from many causes that is heterogenous in its …

In the 3rd year of the SARS-CoV-2 pandemic, much has been learned about the long-term
effects of COVID-19 pneumonia on the lungs. Approximately one-third of patients with …

COVID-19 has been occasionally linked to histologically confirmed cutaneous vasculitis and
a Kawasaki-like vasculitis, with these entities generally having minimal or no lung …

A compelling body of evidence points to pulmonary thrombosis and thromboembolism as a
key feature of COVID-19. As the pandemic spread across the globe over the past few …

Abstract Coronavirus disease 2019 (COVID-19) has become a rapid worldwide pandemic.
While COVID-19 primarily manifests as an interstitial pneumonia and severe acute …

The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …

Abstract SARS-CoV-2 uses ACE2, an inhibitor of the Renin-Angiotensin-Aldosterone
System (RAAS), for cellular entry. Studies indicate that RAAS imbalance worsens the …

Purpose To investigate, in a meta-analysis, the frequency of pulmonary embolism (PE) in
patients with COVID-19 and whether D-dimer assessment may be useful to select patients …

The COVID-19 pandemic has had devastating medical and economic consequences
globally. The severity of COVID-19 is related, in a large measure, to the extent of pulmonary …

Due to its pandemic diffusion, SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus 2) infection represents a global threat. Despite a multiorgan involvement has …